Sectors
Jurisdictions
- Australia
- Brunei
- Cambodia
- China
- Hong Kong
- India
- Indonesia
- Japan
- Laos
- Macau
- Malaysia
- Mongolia
- Myanmar
- Nepal
- New Zealand
- North Korea
- Pakistan
- Philippines
- Singapore
- South Korea
- Sri Lanka
- Taiwan
- Thailand
- Vietnam
- East Timor
- Bangladesh
- Azerbaijan
- Kazakhstan
- Tajikistan
- Egypt
- Cyprus
- Iran
- Israel
- Lebanon
- Kuwait
- Oman
- Jordan
- Bahrain
- Qatar
- Saudi Arabia
- Syria
- UAE
- Turkey
- Pacific Islands
- Russia
- France
- UK
- Canada
- USA
- Latin America
- Africa
Pharmaceutical Companies Must Invest in R&D and IP
Issued: September 07 2013Research in China shows that pharmaceutical companies which rank relatively high in business income are often uneven when it comes to patent grants.
The IP Report on Listed Companies in the Pharmaceutical Industry of China, research initiated by Globe- Law and co-organized by Chinese finance website hexun.com shows that companies which rank relatively high in business income often rank not so high in the overall index indicated in the report. With respect to patent grants, in particular, companies in the pharmaceutical industry remain unbalanced.
“Many companies underperform in this indicator, six of which have no patents,” says the report, which suggests such companies increase investments in R&D and IP.
Among approximately 100 A-share listed pharmaceutical companies, IP distribution differs significantly. When judged by the five ratings on which the scores are calculated, only three companies reach a five-star level, Wang Zhengzhi, a senior partner at Globe-Law in Beijing told IPR in China, a website sponsored by China’s Ministry of Commerce.
“It proves sound capacity for research and development will help companies increase their values,” said Pan Guangcheng, vice president of Chinese Chemical and Pharmaceutical Industry Association.
Related Articles
Law Firms
China
- ADVANCE CHINA I.P. LAW OFFICE
- AFD CHINA INTELLECTUAL PROPERTY LAW OFFICE
- CCPIT PATENT AND TRADEMARK LAW OFFICE
- CHANG TSI & PARTNERS
- CHINA SINDA INTELLECTUAL PROPERTY LIMITED
- CHOFN INTELLECTUAL PROPERTY
- KANGXIN PARTNERS
- KING & WOOD MALLESONS
- LEXFIELD LAW OFFICES
- LIU, SHEN & ASSOCIATES
- PEKSUNG INTELLECTUAL PROPERTY LTD.
- RAJAH & TANN
- RUN MING
- UNITALEN ATTORNEYS AT LAW
- VOSON FORESTSONG IP AGENCY